Ortho evra and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Ortho evra (ethinyl estradiol; norelgestromin), especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years also take Adderall 10, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Blindness when taking Ortho evra. It is created by eHealthMe based on reports of 29,122 people who have side effects when taking Ortho evra from the FDA, and is updated regularly.

What is Ortho evra?

Ortho evra has active ingredients of ethinyl estradiol; norelgestromin. It is often used in birth control. eHealthMe is studying from 29,275 Ortho evra users. Check the latest studies of Ortho evra.

What is Blindness?

Blindness is found to be associated with 1,508 drugs and 1,987 conditions by eHealthMe. Check the latest studies of Blindness.

On Jul, 26, 2026

29,122 people reported to have side effects when taking Ortho evra.
Among them, 14 people (0.05%) have Blindness.

Among these 14 people:

How long have people been on Ortho evra when they have Blindness? *

What is the gender of people who have Blindness when taking Ortho evra? *

female: 92.86 %
male: 7.14 %

What is the age of people who have Blindness when taking Ortho evra? *

What are other drugs people take besides Ortho evra? *

What are other side effects people have besides Blindness? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 35.71%
Vision Blurred: 4 people, 28.57%
Chest Pain: 4 people, 28.57%
Dizziness: 3 people, 21.43%
Headache (pain in head): 3 people, 21.43%
Dyspnea (difficult or laboured breathing): 2 people, 14.29%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 14.29%
Hyperhidrosis (abnormally increased sweating): 2 people, 14.29%
Hypoaesthesia (reduced sense of touch or sensation): 2 people, 14.29%
Irritability: 1 person, 7.14%

What are the existing conditions these people have? *

Thyroid Diseases: 1 person, 7.14%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ortho evra and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ortho evra:

Ortho evra (29,275 reports)

Blindness treatments and more:

Blindness (45,948 reports)

How severe was Blindness and when was it recovered:

Blindness in Ortho evra

Expand to all the drugs that have ingredients of ethinyl estradiol; norelgestromin:

Blindness and drugs with ingredients of ethinyl estradiol; norelgestromin (17 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ortho evra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Blindness (1,508 drugs)

Browse all the conditions that are associated with Blindness:

Blindness (1,987 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norelgestromin (the active ingredients of Ortho evra) and Ortho evra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.